Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 3, 2007, Pages 349-354

  Hilal, Moh'd Abu ^a   Ung, C Tsiang ^a   Westlake, Sarah ^a   Johnson, Colin D ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Carboxypeptidase B; L selectin; Pancreatitis; Severity markers

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CARBOXYPEPTIDASE B ACTIVATION PEPTIDE; L SELECTIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVATION; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE ACTIVATION; PANCREAS INJURY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SCORING SYSTEM;

EID: 33846904345     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04550.x     Document Type: Article

References (40)

1. United Kingdom guidelines for the management of acute pancreatitis. British society of gastroenterology. Gut 1998; 42 (Suppl. 2): S1-13.
2. UK guidelines for the management of acute pancreatitis: first revision. Gut 2005; 54 (Suppl. 3): iii1-iii9.
3. Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N. Engl. J. Med. 1993; 328: 228-32.
4. Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988; 2: 979-83.
5. Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst. Rev. 2003; 4: CD002941.
6. Gudgeon AM, Heath DI, Hurley P et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8.
7. Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998; 42: 97-102.
8. Appelros S, Petersson U, Toh S, Johnson C, Borgstrom A. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br. J. Surg. 2001; 88: 216-21.
9. Muller CA, Appelros S, Uhl W, Buchler MW, Borgstrom A. A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Pancreatology 2003; 3: 149-55.
10. Menger MD, Vollmar B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br. J. Surg. 1996; 83: 588-601.
11. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6.
12. Donnelly SC, Haslett C, Dransfield I et al. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994; 344: 215-19.
13. Muller JC, Buhrer C, Kiening KL et al. Decreased soluble adhesion molecule 1-selectin plasma concentrations after major trauma. J. Trauma 1998; 45: 705-8.
14. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch. Surg. 1993; 128: 586-90.
15. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA 1994; 271: 703-7.
16. Johnson CD, Lempinen M, Imrie CW et al. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br. J. Surg. 2004; 91: 1027-33.
17. Neoptolemos JP, Kemppainen EA, Mayer JM et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-60.
18. Tenner S, Fernandez-del Castillo C, Warshaw A et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int. J. Pancreatol. 1997; 21: 105-10.
19. Gudgeon AM, Patel G, Hermon-Taylor J, Hurley P, Bowyer RC, Jehanli AM. Detection of human pancreatic pro-phospholipase A2 activation using an immunoassay for the free activation peptide DSGISPR. Ann. Clin. Biochem. 1991; 28: 497-503.
20. Buchler MW, Uhl W, Andren-Sandberg A. CAPAP in acute pancreatitis: just another marker or real progress? Gut 1998; 42: 8-9.
21. Appelros S, Borgstrom A. Studies on the turnover of procarboxypeptidase B, its active enzyme and the activation peptide in the pig. Biol. Chem. 1998; 379: 893-8.
22. Muller CA, Appelros S, Uhl W, Buchler MW, Borgstrom A. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002; 51: 229-35.
23. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201-5.
24. Buchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int. J. Pancreatol. 1986; 1: 227-35.
25. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995; 10: 347-53.
26. Rau B, Schilling MK, Beger HG. Laboratory markers of severe acute pancreatitis. Dig. Dis. 2004; 22: 247-57.
27. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br. J. Surg. 1989; 76: 177-81.
28. Spertini O, Schleiffenbaum B, White-Owen C, Ruiz P Jr, Tedder TF. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J. Immunol. Methods 1992; 156: 115-23.
29. Bird MI, Foster MR, Priest R, Malhotra R. Selectins: physiological and pathophysiological roles. Biochem. Soc. Trans. 1997; 25: 1199-206.
30. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J. Clin. Gastroenterol. 2003; 36: 253-60.
31. Simchuk EJ, Traverso LW, Nukui Y, Kozarek RA. Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am. J. Surg. 2000; 179: 352-5.
32. Khan Z, Vlodov J, Horovitz J et al. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Am. J. Gastroenterol. 2002; 97: 1973-7.
33. Buchler M, Malfertheiner P, Uhl W, Beger HG. Diagnostic and prognostic value of serum elastase 1 in acute pancreatitis. Klin. Wochenschr. 1986; 64: 1186-91.
34. Dominguez-Munoz JE, Carballo F, Garcia MJ et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br. J. Surg. 1991; 78: 1230-34.
35. Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-9.
36. Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br. J. Surg. 2001; 88: 222-7.
37. Kylanpaa-Back ML, Takala A, Kemppainen EA et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit. Care Med. 2001; 29: 63-9.
38. Muller CA, Uhl W, Printzen G et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46: 233-8.
39. Neoptolemos JP. Procalcitonin strip test in the early detection of severe acute pancreatitis (Br J Surg 2001; 88: 222-7). Br. J. Surg. 2001; 88: 222-7.
40. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-40.